4//SEC Filing
Louria Hayon Igal 4
Accession 0001213900-24-025519
CIK 0001415397other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:01 PM ET
Size
7.1 KB
Accession
0001213900-24-025519
Insider Transaction Report
Form 4
Louria Hayon Igal
DirectorChief Technology Officer
Transactions
- Exercise of In-Money
Warrants to purchase Common Stock
2023-08-29−999,000→ 0 totalExercise: $0.01From: 2022-12-05Exp: 2024-07-05→ Common Stock (999,000 underlying) - Exercise of In-Money
Common Stock
2023-08-29$0.01/sh+999,000$9,990→ 999,000 total
Footnotes (1)
- [F1]The transaction reported is an exercise of warrants to purchase common stock. In accordance with General Instruction 4(c)(iii), the exercise price is reported under column 2 of this table.
Documents
Issuer
Raphael Pharmaceutical Inc.
CIK 0001415397
Entity typeother
Related Parties
1- filerCIK 0001903781
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:01 PM ET
- Size
- 7.1 KB